Collaborations are essential to AIMM’s mission.
Whether we are collaborating with a treating physician who has identified a patient with a robust response to their treatment, an academic group that has developed unique biology/capabilities to understand how our products work, or with a company that has developed complimentary technology, AIMM will strive to find a win-win structure that enables us to discover and develop new and effective treatments for our patients.
If you have:
- Identified a patient with a strong immune response to their tumor, either spontaneously or as a result of treatment
- Are interested in following the B cell development and maturation during treatment
- unique biological expertise that might push our products forward
- Have a technology that enhances the potency of AIMM’s tumor specific antibodies
- Have capabilities to broadly develop and commercialize antibody therapeutics
…then we would like to collaborate with you.
Please write us at:
AIMM Therapeutics BV
1105 BA Amsterdam
Or send an email to: